vs
AdvanSix Inc.(ASIX)与优尼威(CLMB)财务数据对比。点击上方公司名可切换其他公司
AdvanSix Inc.的季度营收约是优尼威的1.9倍($359.9M vs $193.8M),优尼威净利率更高(3.6% vs -0.8%,领先4.4%),优尼威同比增速更快(19.8% vs 9.4%),过去两年优尼威的营收复合增速更高(44.8% vs 3.4%)
AdvanSix Inc.是一家美国化工企业,主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部,于2016年分拆独立,2019年预估营收达14亿美元,其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
优尼威解决方案是一家全球化学品与原料分销商,同时可为客户提供各类增值服务,在行业内拥有广泛的全球布局与专业服务能力。
ASIX vs CLMB — 直观对比
营收规模更大
ASIX
是对方的1.9倍
$193.8M
营收增速更快
CLMB
高出10.4%
9.4%
净利率更高
CLMB
高出4.4%
-0.8%
两年增速更快
CLMB
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $359.9M | $193.8M |
| 净利润 | $-2.8M | $7.0M |
| 毛利率 | 7.6% | 15.4% |
| 营业利润率 | -0.7% | 4.9% |
| 净利率 | -0.8% | 3.6% |
| 营收同比 | 9.4% | 19.8% |
| 净利润同比 | -892.9% | -0.1% |
| 每股收益(稀释后) | $-0.11 | $1.51 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASIX
CLMB
| Q4 25 | $359.9M | $193.8M | ||
| Q3 25 | $374.5M | $161.3M | ||
| Q2 25 | $410.0M | $159.3M | ||
| Q1 25 | $377.8M | $138.0M | ||
| Q4 24 | $329.1M | $161.8M | ||
| Q3 24 | $398.2M | $119.3M | ||
| Q2 24 | $453.5M | $92.1M | ||
| Q1 24 | $336.8M | $92.4M |
净利润
ASIX
CLMB
| Q4 25 | $-2.8M | $7.0M | ||
| Q3 25 | $-2.6M | $4.7M | ||
| Q2 25 | $31.4M | $6.0M | ||
| Q1 25 | $23.3M | $3.7M | ||
| Q4 24 | $352.0K | $7.0M | ||
| Q3 24 | $22.3M | $5.5M | ||
| Q2 24 | $38.9M | $3.4M | ||
| Q1 24 | $-17.4M | $2.7M |
毛利率
ASIX
CLMB
| Q4 25 | 7.6% | 15.4% | ||
| Q3 25 | 6.8% | 15.9% | ||
| Q2 25 | 14.3% | 16.5% | ||
| Q1 25 | 14.2% | 16.9% | ||
| Q4 24 | 3.4% | 19.3% | ||
| Q3 24 | 14.4% | 20.3% | ||
| Q2 24 | 17.9% | 20.2% | ||
| Q1 24 | 0.9% | 18.4% |
营业利润率
ASIX
CLMB
| Q4 25 | -0.7% | 4.9% | ||
| Q3 25 | -0.9% | 4.3% | ||
| Q2 25 | 7.7% | 5.0% | ||
| Q1 25 | 7.7% | 3.5% | ||
| Q4 24 | -3.9% | 7.2% | ||
| Q3 24 | 7.5% | 7.1% | ||
| Q2 24 | 11.5% | 4.6% | ||
| Q1 24 | -7.0% | 3.8% |
净利率
ASIX
CLMB
| Q4 25 | -0.8% | 3.6% | ||
| Q3 25 | -0.7% | 2.9% | ||
| Q2 25 | 7.7% | 3.7% | ||
| Q1 25 | 6.2% | 2.7% | ||
| Q4 24 | 0.1% | 4.3% | ||
| Q3 24 | 5.6% | 4.6% | ||
| Q2 24 | 8.6% | 3.7% | ||
| Q1 24 | -5.2% | 3.0% |
每股收益(稀释后)
ASIX
CLMB
| Q4 25 | $-0.11 | $1.51 | ||
| Q3 25 | $-0.10 | $1.02 | ||
| Q2 25 | $1.15 | $1.30 | ||
| Q1 25 | $0.86 | $0.81 | ||
| Q4 24 | $0.02 | $1.52 | ||
| Q3 24 | $0.82 | $1.19 | ||
| Q2 24 | $1.43 | $0.75 | ||
| Q1 24 | $-0.65 | $0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $36.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $815.2M | $116.6M |
| 总资产 | $1.7B | $460.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASIX
CLMB
| Q4 25 | $19.8M | $36.6M | ||
| Q3 25 | $23.7M | $49.8M | ||
| Q2 25 | $18.4M | $28.6M | ||
| Q1 25 | $8.3M | $32.5M | ||
| Q4 24 | $19.6M | $29.8M | ||
| Q3 24 | $17.3M | $22.1M | ||
| Q2 24 | $12.1M | $48.4M | ||
| Q1 24 | $20.6M | $43.6M |
总债务
ASIX
CLMB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.2M |
股东权益
ASIX
CLMB
| Q4 25 | $815.2M | $116.6M | ||
| Q3 25 | $818.2M | $109.3M | ||
| Q2 25 | $823.7M | $105.2M | ||
| Q1 25 | $794.4M | $95.6M | ||
| Q4 24 | $774.6M | $90.6M | ||
| Q3 24 | $766.4M | $87.7M | ||
| Q2 24 | $746.6M | $79.8M | ||
| Q1 24 | $713.2M | $76.4M |
总资产
ASIX
CLMB
| Q4 25 | $1.7B | $460.2M | ||
| Q3 25 | $1.7B | $376.1M | ||
| Q2 25 | $1.6B | $420.7M | ||
| Q1 25 | $1.6B | $370.1M | ||
| Q4 24 | $1.6B | $469.2M | ||
| Q3 24 | $1.5B | $371.9M | ||
| Q2 24 | $1.5B | $302.8M | ||
| Q1 24 | $1.5B | $298.3M |
负债/权益比
ASIX
CLMB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.02× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $63.7M | $-11.9M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 7.7% | — |
| 现金转化率经营现金流/净利润 | — | -1.70× |
| 过去12个月自由现金流最近4个季度 | $6.4M | — |
8季度趋势,按日历期对齐
经营现金流
ASIX
CLMB
| Q4 25 | $63.7M | $-11.9M | ||
| Q3 25 | $26.6M | $22.2M | ||
| Q2 25 | $21.1M | $-2.2M | ||
| Q1 25 | $11.4M | $8.5M | ||
| Q4 24 | $64.2M | $16.0M | ||
| Q3 24 | $57.3M | $-3.6M | ||
| Q2 24 | $50.2M | $7.3M | ||
| Q1 24 | $-36.2M | $14.0M |
自由现金流
ASIX
CLMB
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | — | ||
| Q1 24 | $-71.6M | — |
自由现金流率
ASIX
CLMB
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -21.3% | — |
资本支出强度
ASIX
CLMB
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 10.5% | — |
现金转化率
ASIX
CLMB
| Q4 25 | — | -1.70× | ||
| Q3 25 | — | 4.73× | ||
| Q2 25 | 0.67× | -0.37× | ||
| Q1 25 | 0.49× | 2.30× | ||
| Q4 24 | 182.29× | 2.29× | ||
| Q3 24 | 2.57× | -0.66× | ||
| Q2 24 | 1.29× | 2.13× | ||
| Q1 24 | — | 5.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
CLMB
| Distribution Segment | $187.9M | 97% |
| Solutions Segment | $6.0M | 3% |